Centers | ||
Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) | TEST |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
info here |
Partnerships |
Events |
Jobs |
Janssen Pharmaceuticals and Johns Hopkins To Develop New Therapies to Treat Neurological DiseasesJanssen Pharmaceuticals (Formerly OMJPI) a Johnson and Johnson entity has entered into collaboration agreement with Johns Hopkins Brain Science Institute ("BSi") at Johns Hopkins University. Janssen will be working with Johns Hopkins researchers... View all Vanderbilt and Astra Zeneca to Develop New Drugs to Treat Psychosis and Other Brain DisordersUnder a new research collaboration agreement, Vanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Astra Zeneca will work together to develop compounds that act on M4 muscarinic acetylcholine receptor. The agreement entails research... View all Vanderbilt Enters Into Collaboration With BMS to Develop Drugs to treat Parkinsons DiseaseVanderbilt Center for Neuroscience Drug Discovery (VCNDD) and Bristol-Myers Squibb Company have entered into a broad collaboration agreement to co-develop new drugs to treat Parkinsons Disease. Under the collaboration agreement VCNDD will identify... View all |
No EVENTS for listing |
No Job Posts |


